|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.310 AUD | -1.70% |
|
+5.00% | -24.76% |
| 19/06 | EZZ Life Science Launches in the US; Shares Up 10% | MT |
| 19/06 | Ezz Life Science Launches In U.S. Market And Receives FDA Registrations | RE |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Gross Profit: Breakdown by Business Segment
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||
Company Owned | 762K | 11.37M | 8.14M | 32.54M | 62.57M | |
Gross Profit | 662K | 9.34M | 5.44M | 27.39M | 49.95M | |
Non-Durable Goods Distribution | ||||||
Brought in Lines | 16.55M | 10.92M | 6.88M | 4.6M | 3.87M | |
Gross Profit | 2.67M | 3.12M | 2.07M | 1.14M | 991K | |
Wholesale - Miscellaneous | - | - | - | - | - | |
Income Tax Expense | - | - | - | - | - | |
Total Assets | - | - | - | - | - | |
CAPEX | - | - | - | - | - | |
EBT | - | - | - | - | - | |
D&A | - | - | - | - | - | |
Net Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
Mainland China | - | 10.13M | 4.35M | 26.8M | 52.43M | |
Australia and New Zealand | - | 12.01M | 9.43M | 9.76M | 11.24M | |
Other Countries/Regions | - | 150K | 1.24M | 585K | 2.77M | |
China | - | - | - | - | - | |
Australia | - | - | - | - | - | |
Total Assets | 6.19M | 12.04M | 14.27M | 17.64M | 25.55M |
- Stock Market
- Equities
- EZZ Stock
- Financials EZZ Life Science Holdings Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition